INHALE-3 extension study: Inhaled technosphere insulin plus insulin degludec maintains glycemic control
A new study in the journal Diabetes Technology & Therapeutics evaluated the effects of a regimen of inhaled technosphere ...
EurekAlert!6d
Evaluation of inhaled technosphere insulin plus insulin degludec for adults with type 1 diabetes
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) concluded that inhaled technosphere insulin ...
Knowridge Science Report10d
This drug lowers blood sugar and body weight faster than other diabetes drugs
A new study has found that the diabetes drug tirzepatide helps people lower their blood sugar and lose weight more quickly ...
EurekAlert!4d
Results of the INHALE-3 extension study: inhaled technosphere insulin plus insulin degludec in T1D
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the effects of a regimen of inhaled technosphere insulin (TI) and insulin degludec over 30 weeks and its ...
Healio4d
Inhaled insulin lowers HbA1c at 30 weeks in adults with type 1 diabetes
Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...
pharmaphorum3d
Novo Nordisk’s diabetes treatments approved in EU
The approval covers all 27 European Union member states. Tresiba (insulin degludec) is a once-daily new-generation based insulin analogue with an ultra-long duration of action. Ryzodeg (insulin ...
pharmaphorum5d
Novo Nordisk once-weekly insulin clears first phase 3 test
The results of the ONWARDS 2 trial of insulin icodec showed that it was as effective as daily dosing with Novo Nordisk's Tresiba (insulin degludec) once per day at controlling blood glucose, as ...
News Medical1y
Ryzodeg 70/30 Penfill
Ryzodeg ® 70/30 contains two types of insulin: Basal insulin called insulin degludec - this has a long blood sugar level lowering effect. Rapid-acting insulin called insulin aspart - this lowers ...